Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 5/2013

01-10-2013 | Original Article

Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study

Authors: Rikiya Taoka, Yoshikazu Togo, Tatsuhiko Kubo, Masahito Kido, Kenta Miki, Hiroshi Kiyota, Shin Egawa, Takashi Sugawara, Mitsuru Yasuda, Masahiro Nakano, Takashi Deguchi, Masashi Nishino, Kiyohito Ishikawa, Ryoichi Shiroki, Minori Matsumoto, Katsumi Shigemura, Kazushi Tanaka, Soichi Arakawa, Masato Fujisawa, Koichiro Wada, Toyohiko Watanabe, Hiromi Kumon, Kanao Kobayashi, Akio Matsubara, Takehiko Sho, Ryoichi Hamasuna, Tetsuro Matsumoto, Hiroshi Hayami, Masayuki Nakagawa, Shingo Yamamoto

Published in: Journal of Infection and Chemotherapy | Issue 5/2013

Login to get access

Abstract

To propose an appropriate prophylactic antimicrobial therapy for patients undergoing brachytherapy, we evaluated the relationships between various antimicrobial prophylaxis (AMP) protocols and the incidence of postimplant infections in a multicenter cohort study conducted in Japan. The records of 826 patients with localized prostate cancer who underwent a transperineal 125I brachytherapy procedure between January 2009 and December 2010 were retrospectively reviewed. Perioperative infections, including surgical site and remote infections, were recorded up to postoperative day 30. A total of 6 (0.73 %) patients had a perioperative infection following seed implantation, of whom all received AMP for 1 or more days. None of the patients who received a single-dose protocol of AMP using fluoroquinolone p.o. or penicillin with a beta-lactamase inhibitor i.v. developed a perioperative infection. Statistical analysis showed that a single-dose protocol was more significantly related to a lower risk of perioperative infection as compared to the other AMP protocols examined (p = 0.045). Furthermore, our results indicated that bacteriuria and preoperative hair removal were risk factors of perioperative infection with statistical significance (p = 0.007, p = 0.004). Analysis of patient clinical parameters, including age, American Society of Anesthesiologists score, diabetes mellitus, prostate volume, numbers of implanted seeds and needle punctures, operation time, and indwelling duration time of the Foley catheter, did not reveal significant differences in terms of perioperative infection. Our results indicated that a single-dose AMP protocol is sufficient to prevent perioperative infections following seed implantation. On the other hand, AMP is only one of several measures to prevent perioperative infectious complications. It is necessary to know that the patient must have no bacteriuria and that preoperative hair removal should be avoided.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef
2.
go back to reference Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178:14–9.CrossRef Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178:14–9.CrossRef
3.
go back to reference Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer: results from a prospective, population-based randomized controlled trial. Eur Urol. 2007;51(3):659–64.PubMedCrossRef Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer: results from a prospective, population-based randomized controlled trial. Eur Urol. 2007;51(3):659–64.PubMedCrossRef
4.
go back to reference Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175(5):1605–12.PubMedCrossRef Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175(5):1605–12.PubMedCrossRef
5.
go back to reference Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117–23.PubMedCrossRef Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117–23.PubMedCrossRef
6.
go back to reference Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44(4):789–99.PubMedCrossRef Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44(4):789–99.PubMedCrossRef
8.
go back to reference Hoffelt SC, Wallner K, Merrick G. Epididymitis after prostate brachytherapy. Urology. 2004;63(2):293–6.PubMedCrossRef Hoffelt SC, Wallner K, Merrick G. Epididymitis after prostate brachytherapy. Urology. 2004;63(2):293–6.PubMedCrossRef
9.
go back to reference Gilmore PE, Baird AD, Javle PM. Prostate abscess: a rare complication of brachytherapy for prostate cancer. Ann R Coll Surg Engl. 2009;91(4):W12–4.PubMedCrossRef Gilmore PE, Baird AD, Javle PM. Prostate abscess: a rare complication of brachytherapy for prostate cancer. Ann R Coll Surg Engl. 2009;91(4):W12–4.PubMedCrossRef
11.
go back to reference Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–90.PubMedCrossRef Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–90.PubMedCrossRef
12.
go back to reference Machtens S, Baumann R, Hagemann J, Warszawski A, Meyer A, Karstens JH, et al. Long-term results of interstitial brachytherapy (LDR brachytherapy) in the treatment of patients with prostate cancer. World J Urol. 2006;24(3):289–95.PubMedCrossRef Machtens S, Baumann R, Hagemann J, Warszawski A, Meyer A, Karstens JH, et al. Long-term results of interstitial brachytherapy (LDR brachytherapy) in the treatment of patients with prostate cancer. World J Urol. 2006;24(3):289–95.PubMedCrossRef
13.
go back to reference Chen AB, D’Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol. 2006;24(33):5298–304.PubMedCrossRef Chen AB, D’Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol. 2006;24(33):5298–304.PubMedCrossRef
14.
go back to reference Nomura T, Hirai K, Yamasaki M, Inoue T, Takahashi M, Kawashima T, et al. Efficacy of prophylactic single-dose therapy using fluoroquinolone for prostate brachytherapy. Jpn J Radiol. 2012;30:317–22.PubMedCrossRef Nomura T, Hirai K, Yamasaki M, Inoue T, Takahashi M, Kawashima T, et al. Efficacy of prophylactic single-dose therapy using fluoroquinolone for prostate brachytherapy. Jpn J Radiol. 2012;30:317–22.PubMedCrossRef
15.
go back to reference Dicker AP, Figura AT, Waterman FM, Valicenti RK, Strup SE, Gomella LG. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech Urol. 2000;6(2):104–8.PubMed Dicker AP, Figura AT, Waterman FM, Valicenti RK, Strup SE, Gomella LG. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech Urol. 2000;6(2):104–8.PubMed
16.
go back to reference Alicia JM, Teresa CH, Michele LP, Leah CS, William RJ. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27(2):97–132.CrossRef Alicia JM, Teresa CH, Michele LP, Leah CS, William RJ. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27(2):97–132.CrossRef
Metadata
Title
Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study
Authors
Rikiya Taoka
Yoshikazu Togo
Tatsuhiko Kubo
Masahito Kido
Kenta Miki
Hiroshi Kiyota
Shin Egawa
Takashi Sugawara
Mitsuru Yasuda
Masahiro Nakano
Takashi Deguchi
Masashi Nishino
Kiyohito Ishikawa
Ryoichi Shiroki
Minori Matsumoto
Katsumi Shigemura
Kazushi Tanaka
Soichi Arakawa
Masato Fujisawa
Koichiro Wada
Toyohiko Watanabe
Hiromi Kumon
Kanao Kobayashi
Akio Matsubara
Takehiko Sho
Ryoichi Hamasuna
Tetsuro Matsumoto
Hiroshi Hayami
Masayuki Nakagawa
Shingo Yamamoto
Publication date
01-10-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 5/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-013-0610-0

Other articles of this Issue 5/2013

Journal of Infection and Chemotherapy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine